US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

689.59

-11.4736-1.64%

Number of Gainers:45

Number of Losers:100

Number of Flat:9

PE:- -

High:703.50

Open:700.87

Low:686.25

Close:701.07

Volume:325.61M

Turnover:9.76B

Market Cap:481.91B

Float Cap:365.77B

Loading ...

Grace Therapeutics files to sell 4.76M shares of common stock for holders

Karooooo CEO, Executive Chairman Calisto Isaias Jose Sells 6,202 Shares for $393,817.14

Twin Vee PowerCats Raises CEO Visconti Base Salary to $250,000

Jiuzi Holdings Reports 51,512,759 Ordinary Shares Outstanding as of Aug. 24, 2026

Press Release: Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer

Biomea Shares Rise After Completing Enrollment in Diabetes Trial

MT Newswires Live

Coinbase Says Users May Experience Degraded Performance When Withdrawing Funds to PayPal

Coinbase Global Selects Chainlink to Provide Pricing Data for Tokenized Stocks

MT Newswires Live

High Insider Ownership Drives Growth Stocks In August 2026

Simply Wall St.

Undervalued Penny Stocks To Consider In August 2026

Simply Wall St.

Lineage Cell Therapeutics management to meet with B. Riley

Coinbase selects Chainlink to bring tokenized stocks to DeFi users

Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT)

Aveanna Healthcare's Growth Trajectory Supported by Secular Tailwinds, RBC Says

MT Newswires Live

Global-E COO Tamari Shahar Sells 24,999 Shares for $1.04 Million

Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages

Agilon Health Price Target Raised to $85.00/Share from $31.00 by JP Morgan

Erasca Wins FDA Fast Track for Pancreatic Therapy

Aveanna price target raised to $15 from $11 at Truist

Zhihu Inc Expected to Post a Loss of 7 Fen a Share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK4539/news?page=25"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":689.5945,"timestamp":1788292799999,"preClose":701.0681,"halted":0,"volume":325607950,"delay":0,"changeRate":-0.016366,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-11.473633,"latestTime":"09-01 16:00:00 EDT","open":700.8716,"high":703.5049,"low":686.25476,"amount":9755081900.67638,"amplitude":0.024605,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.432809,"peRate":146.331834,"turnoverRate":0.025137,"increases":45,"decrements":100,"flats":6,"marketCap":481907544284.625,"floatMarketCap":365773227048.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":703.5049,"amplitude":0.024605,"preClose":701.0681,"low":686.25476,"pbRate":"5.432809","latestPrice":689.5945,"volume":325607950,"delay":0,"open":700.8716,"prevYearClose":881.5255,"prevWeekClose":700.4571,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":710.5842,"twentyDayClose":709.8907,"sixtyDayClose":711.562,"secType":"PLATE","market":"US","turnoverRate":0.025137,"peRate":146.331834,"marketCap":481907544284.625,"floatMarketCap":365773227048.75,"timestamp":1788292799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":45,"down":100,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:25,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662206506","title":"Grace Therapeutics files to sell 4.76M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206506?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:15","pubTimestamp":1787602518,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 4.76M shares of common stock. The company is not s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grace-therapeutics-files-to-sell-4-76m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grace-therapeutics-files-to-sell-4-76m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662393206","title":"Karooooo CEO, Executive Chairman Calisto Isaias Jose Sells 6,202 Shares for $393,817.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2662393206","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662393206?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:14","pubTimestamp":1787602453,"startTime":"0","endTime":"0","summary":"Karooooo CEO, Executive Chairman Calisto Isaias Jose sells 6,202 shares for $393,817.14Karooooo beneficial owner Calisto Isaias Jose, CEO executive chairman, sold 6,202 common shares on Aug. 21.Sale p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL1VsCZq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Karooooo CEO, Executive Chairman Calisto Isaias Jose Sells 6,202 Shares for $393,817.14","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","KARO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206892","title":"Twin Vee PowerCats Raises CEO Visconti Base Salary to $250,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206892","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206892?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:06","pubTimestamp":1787602005,"startTime":"0","endTime":"0","summary":"Twin Vee PowerCats raises CEO Visconti base salary to $250,000Twin Vee PowerCats revised CEO Joseph Visconti’s base salary to USD 250,000 on Aug. 21, 2026.Bonus eligibility set at USD 150,000 tied to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL90rV5M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4190","VEEE","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068982","title":"Jiuzi Holdings Reports 51,512,759 Ordinary Shares Outstanding as of Aug. 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068982","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662068982?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:06","pubTimestamp":1787601965,"startTime":"0","endTime":"0","summary":"Jiuzi Holdings reports 51,512,759 ordinary shares outstanding as of Aug. 24, 2026Jiuzi Holdings reported 51,512,759 ordinary shares issued and outstanding as of Aug. 24, 2026.Share count rose from the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9NZvTd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JZXN","BK4539","BK4214"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662920503","title":"Press Release: Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662920503","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662920503?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601660,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (\"Oruka\") (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4232","BK4007","BK4139","LU0889565916.HKD","LU0109394709.USD","LENZ","R","BK4022","LU0320765992.SGD","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203426","title":"Biomea Shares Rise After Completing Enrollment in Diabetes Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203426","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203426?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:47","pubTimestamp":1787597276,"startTime":"0","endTime":"0","summary":"Biomea Fusion  shares rose over 14% in Monday trading after the firm said it has completed enrollment in a phase 2 trial of icovamenib in insulin-deficient Type 2 diabetes patients.The clinical-stage firm said topline 26-week primary endpoint data from the COVALENT-211 trial is expected in Q1 of 2027.Biomea also said COVALENT-212 mid-stage trial enrollment is still ongoing, with topline 26-week primary endpoint data anticipated in Q2 of 2027.Price: 1.57, Change: +0.20, Percent Change: +14.60","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4585","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662164203","title":"Coinbase Says Users May Experience Degraded Performance When Withdrawing Funds to PayPal","url":"https://stock-news.laohu8.com/highlight/detail?id=2662164203","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662164203?lang=en_us&edition=fundamental","pubTime":"2026-08-25 02:35","pubTimestamp":1787596547,"startTime":"0","endTime":"0","summary":"BRIEF-Coinbase Says Users May Experience Degraded Performance When Withdrawing Funds To PayPalAug 24 (Reuters)-Coinbase Global:COINBASE: SOME USERS MAY EXPERIENCE LATENCY OR DEGRADED PERFORMANCE WHEN WITHDRAWING FUNDS TO PAYPAL- WEBSITE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICOI","BITQ","BLCK","BK4600","COIX","BK4535","BK4595","BK4551","LU1861559042.SGD","COIG","BK4516","COIW","LU2360107671.USD","CONY","COII","LU1861220207.SGD","FINX","CONL","IBLC","FIAT","BK4554","LU1861558580.USD","COIA","COIO","COIN","CRPT","LU1861217088.USD","BK4539","BK4596","CONI","BK4112","BKCH","FDIG","CONX","DAPP","BK4585","BK4588","COYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662320840","title":"Coinbase Global Selects Chainlink to Provide Pricing Data for Tokenized Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320840","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320840?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:30","pubTimestamp":1787592637,"startTime":"0","endTime":"0","summary":"Coinbase Global  said Monday it has selected Chainlink to provide continuous pricing data for its recently launched tokenized stocks.Builders across the Base decentralized finance, or DeFi, ecosystem will have access to continuous pricing for Coinbase's tokenized stocks through Chainlink Data Feeds, enabling users to lend, borrow, and trade the tokenized equities, Coinbase said.Shares of Coinbase were down more than 2% in Monday trading.Price: 182.48, Change: -4.02, Percent Change: -2.15","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","COIO","BK4585","COIG","BK4516","FDIG","BK4596","BK4600","ICOI","BK4551","COIA","COIN","LU2360107671.USD","CONY","CRPT","LU1861220207.SGD","BK4595","CONI","COII","BLCK","LINK.USD.CC","BITQ","FINX","IBLC","CONX","BK4112","BKCH","COIX","LU1861217088.USD","LU1861558580.USD","BK4539","COIW","COYY","BK4554","CONL","BK4535","LU1861559042.SGD","FIAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208445","title":"High Insider Ownership Drives Growth Stocks In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208445","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208445?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:05","pubTimestamp":1787591143,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has experienced a slight dip of 1.2%, although it has shown robust growth over the past year with an 18% increase and earnings are projected to grow by 17% annually. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the company's operations and future prospects.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-bwmn/bowman-consulting-group/news/high-insider-ownership-drives-growth-stocks-in-august-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-bwmn/bowman-consulting-group/news/high-insider-ownership-drives-growth-stocks-in-august-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LILA","BK4113","BK4089","BK4559","BK4551","BK4539","BK4129","DDL","BWMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208429","title":"Undervalued Penny Stocks To Consider In August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208429","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208429?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:05","pubTimestamp":1787591111,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the U.S. market has dropped by 1.2%, yet it has shown an impressive rise of 18% over the past year, with earnings forecasted to grow annually by 17%. In this context, identifying stocks that combine affordability with growth potential can be particularly appealing to investors. Although 'penny stocks' might seem like a term from a bygone era, they remain relevant as they often represent smaller or newer companies capable of delivering significant returns when backed by...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/otc-raas.y/cloopen-group-holding/news/undervalued-penny-stocks-to-consider-in-august-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/otc-raas.y/cloopen-group-holding/news/undervalued-penny-stocks-to-consider-in-august-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NAUT","BK4539","BK4121","SERA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662120839","title":"Lineage Cell Therapeutics management to meet with B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662120839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662120839?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:50","pubTimestamp":1787590209,"startTime":"0","endTime":"0","summary":"Meeting to be held on August 25 in San Francisco and in Los Angeles on August 26 hosted by R. Riley. Published first on TheFly – the ultimate sourc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lineage-cell-therapeutics-management-to-meet-with-b-riley-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lineage-cell-therapeutics-management-to-meet-with-b-riley-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539","LINE","BK4224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662707272","title":"Coinbase selects Chainlink to bring tokenized stocks to DeFi users","url":"https://stock-news.laohu8.com/highlight/detail?id=2662707272","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662707272?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:25","pubTimestamp":1787588720,"startTime":"0","endTime":"0","summary":"Coinbase (COIN) announced that it has selected Chainlink as its official oracle infrastructure powering its newly launched Tokenized Stocks, unlock...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coinbase-selects-chainlink-to-bring-tokenized-stocks-to-defi-users-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coinbase-selects-chainlink-to-bring-tokenized-stocks-to-defi-users-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861220207.SGD","LU1861558580.USD","BK4112","CRPT","BK4585","BK4516","COIW","COII","ICOI","COIX","BK4554","BK4535","LU2360107671.USD","FDIG","BITQ","FINX","CONX","BK4596","BK4600","BK4539","BK4588","BLCK","COYY","LU1861217088.USD","IBLC","BK4551","LINK.USD.CC","COIG","COIO","CONL","CONY","BK4595","BKCH","LU1861559042.SGD","COIA","CONI","FIAT","COIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661277313","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661277313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661277313?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:50","pubTimestamp":1787583009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT). Lexicon Pharma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-lexicon-pharmaceuticals-lxrx-and-maxcyte-mxct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-lexicon-pharmaceuticals-lxrx-and-maxcyte-mxct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4581","XLV","LXRX","HCSG","LU0128526141.USD","MXCT","LU0029874061.USD","BK4539","BK4121","BK4585","BK4007","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661027228","title":"Aveanna Healthcare's Growth Trajectory Supported by Secular Tailwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2661027228","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661027228?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:47","pubTimestamp":1787582821,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings  is facing secular tailwinds that back its growth trajectory, as evidenced by the company's increased fiscal 2026 outlook, RBC Capital Markets said in a Friday note.The company's management reiterated its view that private duty nursing, or PDN, appears insulated from potential Medicaid budgetary pressures related to the One Big Beautiful Bill Act, according to the note.Aveanna is also positioned to benefit from the upcoming PDN rate increase in California, as the state's 2027 budget includes a major investment in pediatric private duty nursing rates effective Jan. 1, 2027, RBC said.The investment firm expects the company's private duty services volumes to accelerate in the second half of 2026 and increase materially in 2027.RBC also noted Aveanna's ongoing preferred payor momentum across all of its segments, with the number of preferred-payor agreements nearing or meeting its 2026 targets.RBC raised its price target on Aveanna Healthcare Holdings to $16 from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0128526141.USD","BK4196","LABU","BK4581","LU0029874061.USD","BK4137","AVAH","XBI","BK4588","XLV","BK4539","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661162272","title":"Global-E COO Tamari Shahar Sells 24,999 Shares for $1.04 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661162272","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661162272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:43","pubTimestamp":1787582621,"startTime":"0","endTime":"0","summary":"Global-e COO Tamari Shahar sells 24,999 shares for $1.04 millionGlobal-e Online COO and director Tamari Shahar sold 24,999 ordinary shares on Aug. 19 at USD 41.63.Direct holdings fell to 3,856,689 ord","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL1t1mV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Global-E COO Tamari Shahar Sells 24,999 Shares for $1.04 Million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4122","BK4539","BK4220","GLBE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661742342","title":"Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages","url":"https://stock-news.laohu8.com/highlight/detail?id=2661742342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661742342?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:09","pubTimestamp":1787580540,"startTime":"0","endTime":"0","summary":"Shares of Cytek Biosciences fell after the company said it would challenge a jury's decision to make it pay $56 million in damages in a patent infringement case.The stock was down 7.2% at $4.47 Monday. Shares are now down 12% since the start of the year.The company said Friday that in a patent infringement lawsuit brought by Beckman Coulter, a jury found in Cytek's favor on three of four claims. On the remaining claim, the jury found no literal infringement, but did find infringement under the doctrine of equivalents.The jury awarded past damages consisting of $20 million in lost profit and $36.1 million in royalties. Cytek said it would pursue post-verdict motions challenging the jury's infringement finding and the related damages.Beckman Coulter had alleged that Cytek's Aurora flow cytometers violated Beckman's patent rights for technology used in its CytoFLEX platform.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","IE000M9KFDE8.USD","LU1917777945.USD","SG9999001176.SGD","IE0004445239.USD","LU1551013342.USD","LU1923622614.USD","BK4533","LU0390134368.USD","LU1023059063.AUD","LU1057294990.SGD","DHR","SG9999001176.USD","BK4581","LU0820562030.AUD","IE00BQXX3D17.EUR","LU0187121727.USD","LU1791710582.SGD","LU2125909593.SGD","LU0097036916.USD","LU0320765059.SGD","SGXZ57979304.SGD","LU0289739343.SGD","BK4504","LU2106854487.HKD","LU2211814178.USD","LU0432979614.USD","LU2355687059.USD","SG9999013999.USD","LU0289961442.SGD","LU0689472784.USD","LU1791710400.SGD","LU1804176565.USD","BK4534","LU2244417387.USD","FMED","LU0289960550.SGD","BK4588","BK4539","LU1551013425.SGD","LU2125910179.SGD","SGXZ23171101.USD","LU1267930730.SGD","LU0109391861.USD","CTKB","LU1923621640.USD","LU2112291526.USD","LU0157215616.USD","LU0820561818.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661274143","title":"Agilon Health Price Target Raised to $85.00/Share from $31.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661274143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661274143?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:07","pubTimestamp":1787580420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGL/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGL","BK4196","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727976","title":"Erasca Wins FDA Fast Track for Pancreatic Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727976","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727976?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:48","pubTimestamp":1787575690,"startTime":"0","endTime":"0","summary":"Erasca ( ($ERAS) ) has shared an announcement. On August 24, 2026, Erasca, Inc. reported that the U.S. Food and Drug Administration granted Fast Tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/erasca-wins-fda-fast-track-for-pancreatic-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/erasca-wins-fda-fast-track-for-pancreatic-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ERAS","BK4539","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661796152","title":"Aveanna price target raised to $15 from $11 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2661796152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661796152?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:37","pubTimestamp":1787575061,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Aveanna (AVAH) to $15 from $11 and keeps a Hold rating on the shares. The firm is updating its estimates t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aveanna-price-target-raised-to-15-from-11-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aveanna-price-target-raised-to-15-from-11-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4539","AVAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276012","title":"Zhihu Inc Expected to Post a Loss of 7 Fen a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276012","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276012?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:32","pubTimestamp":1787574736,"startTime":"0","endTime":"0","summary":"Zhihu Inc <ZH.N> expected to post a loss of7fen a share - Earnings PreviewZhihu IncZH.N,ZHis expected to  show a fall in quarterly revenue when it reports  results on August 26 for the period ending June 30 2026The Beijing-based  company is expected to report a 1.0% decrease in revenue to CNY709.517 million from CNY716.89 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst estimate for Zhihu Inc is for a loss of 7 fen per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The average consensus recommendation for the online services peer group is also \"Buy\".Wall Street's median 12-month price target for Zhihu Inc is $4.20, about 30.4% above its last closing price of $3.22This summary was machine generated August 24 at 12:32 GMT.  All figures in Chinese yuan renminbi unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL8N44L0VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZH","HK0000500386.USD","HK0000252160.HKD","BK4509","02390","BK4539","BK4077","BK1095","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":41,"pageCount":25,"totalSize":820,"code":"91000000","status":"200"}]}}